Survival experiments performed over a longer time period showed that combining ATM inhibition with immunotherapy increased the overall survival compared with single treatments alone in both tumor models (Fig. 6Q and R; Supplementary Fig. S7C and D). This evidence concerns the gene ATM and neoplasm.